Earnings Releases·Nov 5, 2026, 4:04 PM ET

Doximity — Fiscal 2027 Second Quarter Earnings Summary

Total revenue increased 4% year-over-year to $174.5 million, while net income and non-GAAP net income margins contracted to 19.9% and 39.1% respectively, driven by a 37% increase in stock-based compensation to $40.6 million.
Adjusted EBITDA declined 12% year-over-year to $88.9 million, though management maintained a 51% adjusted EBITDA margin for the quarter and reported $91.3 million in free cash flow.
Fiscal 2027 guidance was updated to revenue between $678 million and $683 million and Adjusted EBITDA between $317 million and $325 million, with Q3 2027 revenue guidance set at $195 million to $196 million.
The company repurchased $54.2 million of common stock during the quarter and noted that over 190 health systems have purchased its AI suite, while maintaining a network of more than 85% of U.S. physicians.